Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
Journal of Clinical Medicine|March 25, 2022
Cardiovascular Risk Perception and Knowledge among Italian Women: Lessons from IGENDA ProtocolSilvia Maffei, Antonella Meloni, Martino Deidda, et al.Current Problems in Cardiology|December 28, 2023
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answersDaniela Di Lisi, Christian Cadeddu Dessalvi, Concetta Zito, et al.European Journal of Radiology|February 18, 2022
Non-invasive coronary imaging in patients with COVID-19: A narrative reviewCarlotta Onnis, Giuseppe Muscogiuri, Pier Paolo Bassareo, et al.Metabolites|February 26, 2026
Metabolomic Signatures and Advanced Echocardiography Highlight Clinical Risk and Early Cardiac Changes in Systemic Lupus Erythematosus: Six-Year Follow-UpNicola Campana, Michele Migliari, Antonio Deidda, et al.Antioxidants (Basel, Switzerland)|July 26, 2020
Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)Valentina Mercurio, Alessandra Cuomo, Christian Cadeddu Dessalvi, et al.Antioxidants & Redox Signaling|April 12, 2017
From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational OverviewCarlo Gabriele Tocchetti, Christian Cadeddu, Daniela Di Lisi, et al.Biomedicines|August 29, 2024
Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-MetabolismVincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 2, 2023
Impact of COVID-19 on the cardiovascular health of women: a review by the Italian Society of Cardiology Working Group on 'gender cardiovascular diseases'Federica Moscucci, Sabina Gallina, Valentina Bucciarelli, et al.Biomolecules|February 24, 2024
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and BeyondUmberto Attanasio, Elena Di Sarro, Lucia Tricarico, et al.International Journal of Molecular Sciences|June 12, 2026
Heart-Type Fatty Acid-Binding Protein (H-FABP) as a Candidate Adjunctive Biomarker for Immune Checkpoint Inhibitor-Related Cardiotoxicity: Linking Early Immune-Metabolic Myocardial Injury with Translational Cardio-OncologyVincenzo Quagliariello, Massimiliano Berretta, Fabrizio Maurea, et al.Pageof 11